Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab.

Qureshi AI, Saad M, Zaidat OO, Suarez JI, Alexander MJ, Fareed M, Suri K, Ali Z, Hopkins LN.

Stroke. 2002 Jul;33(7):1916-9.

PMID:
12105375
[PubMed - indexed for MEDLINE]
Free Article
2.

Abciximab as an adjunct to high-risk carotid or vertebrobasilar angioplasty: preliminary experience.

Qureshi AI, Suri MF, Khan J, Fessler RD, Guterman LR, Hopkins LN.

Neurosurgery. 2000 Jun;46(6):1316-24; discussion 1324-5.

PMID:
10834637
[PubMed - indexed for MEDLINE]
3.

Carotid angioplasty and stent placement: a prospective analysis of perioperative complications and impact of intravenously administered abciximab.

Qureshi AI, Suri MF, Ali Z, Kim SH, Lanzino G, Fessler RD, Ringer AJ, Guterman LR, Hopkins LN.

Neurosurgery. 2002 Mar;50(3):466-73; discussion 473-5.

PMID:
11841713
[PubMed - indexed for MEDLINE]
4.

Abciximab bolus injection does not reduce cerebral ischemic complications of elective carotid artery stenting: a randomized study.

Hofmann R, Kerschner K, Steinwender C, Kypta A, Bibl D, Leisch F.

Stroke. 2002 Mar;33(3):725-7.

PMID:
11872895
[PubMed - indexed for MEDLINE]
Free Article
5.

Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting.

Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E.

Stroke. 2003 Nov;34(11):2560-7. Epub 2003 Oct 16.

PMID:
14563968
[PubMed - indexed for MEDLINE]
Free Article
7.

Acute basilar artery occlusion treated with combined intravenous Abciximab and intra-arterial tissue plasminogen activator: report of 3 cases.

Eckert B, Koch C, Thomalla G, Roether J, Zeumer H.

Stroke. 2002 May;33(5):1424-7.

PMID:
11988626
[PubMed - indexed for MEDLINE]
Free Article
8.

Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.

Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML; GUSTO IV-ACS Investigators.

Am Heart J. 2004 May;147(5):865-73.

PMID:
15131544
[PubMed - indexed for MEDLINE]
9.

Safety of high-dose intravenous eptifibatide as an adjunct to internal carotid artery angioplasty and stent placement: a prospective registry.

Qureshi AI, Siddiqui AM, Hanel RA, Xavier AR, Kim SH, Kirmani JF, Boulos AS, Hopkins LN.

Neurosurgery. 2004 Feb;54(2):307-16; discussion 316-7.

PMID:
14744276
[PubMed - indexed for MEDLINE]
10.

Intracarotid abciximab injection to abort impending ischemic stroke during carotid angioplasty.

Ho DS, Wang Y, Chui M, Wang Y, Ho SL, Cheung RT.

Cerebrovasc Dis. 2001;11(4):300-4.

PMID:
11385208
[PubMed - indexed for MEDLINE]
11.

Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.

Qureshi AI, Harris-Lane P, Kirmani JF, Janjua N, Divani AA, Mohammad YM, Suarez JI, Montgomery MO.

Neurosurgery. 2006 Oct;59(4):789-96; discussion 796-7.

PMID:
16915119
[PubMed - indexed for MEDLINE]
12.

Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.

Bagur R, Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Nguyen CM, Noel B, Larochellière RD, Poirier P, Costerousse O, Roy L.

Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1010-6. doi: 10.1002/ccd.22235.

PMID:
19753635
[PubMed - indexed for MEDLINE]
13.

Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study.

van den Merkhof LF, Zijlstra F, Olsson H, Grip L, Veen G, Bär FW, van den Brand MJ, Simoons ML, Verheugt FW.

J Am Coll Cardiol. 1999 May;33(6):1528-32.

PMID:
10334418
[PubMed - indexed for MEDLINE]
Free Article
14.

A randomized trial comparing clopidogrel versus ticlopidine therapy in patients undergoing infarct artery stenting for acute myocardial infarction with abciximab as adjunctive therapy.

Parodi G, Sciagrà R, Migliorini A, Memisha G, Moschi G, Valenti R, Pupi A, Antoniucci D.

Am Heart J. 2005 Aug;150(2):220.

PMID:
16086921
[PubMed - indexed for MEDLINE]
16.

Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement.

Arab D, Yahia AM, Qureshi AI.

Int J Cardiovasc Intervent. 2003;5(2):61-6. Review.

PMID:
12745860
[PubMed - indexed for MEDLINE]
17.

Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

Sibbing D, Bernlochner I, Schulz S, Massberg S, Schömig A, Mehilli J, Kastrati A.

J Am Coll Cardiol. 2012 Jul 31;60(5):369-77. doi: 10.1016/j.jacc.2012.02.044. Epub 2012 Jun 6.

PMID:
22682553
[PubMed - indexed for MEDLINE]
Free Article
18.

Fatal cerebral hemorrhage and severe thrombocytopenia during abciximab treatment.

Vahdat B, Canavy I, Fourcade L, Garcia E, Quilici J, Bonnet JL, Bory M.

Catheter Cardiovasc Interv. 2000 Feb;49(2):177-80.

PMID:
10642768
[PubMed - indexed for MEDLINE]
19.

Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).

Zahn R, Haubelt H, Bechtloff S, Schneider S, Frilling B, Rustige J, Marsalek P, Seidl K, Senges J, Hellstern P.

Herz. 2003 Aug;28(5):445-52.

PMID:
12928744
[PubMed - indexed for MEDLINE]
20.

Abciximab in carotid stenting for postsurgical carotid restenosis: intermediate results.

Schneiderman J, Morag B, Gerniak A, Rimon U, Varon D, Seligsohn U, Shotan A, Adar R.

J Endovasc Ther. 2000 Aug;7(4):263-72.

PMID:
10958289
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk